Clinical Trials Browser

INDUSTRY × Breast Diseases × Trastuzumab × Clear all

NCT06886659 2025-07-22

A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)

Phase 1 Completed

Breast Diseases, Breast Neoplasms